Literature DB >> 15755296

Pulmonary hypertension and thalidomide therapy in multiple myeloma.

Yutaka Hattori, Masayuki Shimoda, Shinichiro Okamoto, Toru Satoh, Tsunayuki Kakimoto, Yasuo Ikeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15755296     DOI： 10.1111/j.1365-2141.2005.05389.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Pulmonary arterial hypertension in primary amyloidosis.

Authors:  Meghan M Cirulis; Lyska L Emerson; David A Bull; Nathan Hatton; Jose Nativi-Nicolai; Gerhard C Hildebrandt; John J Ryan
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

Review 2.  Future perspectives for the treatment of pulmonary arterial hypertension.

Authors:  Hossein A Ghofrani; Robyn J Barst; Raymond L Benza; Hunter C Champion; Karen A Fagan; Friedrich Grimminger; Marc Humbert; Gérald Simonneau; Duncan J Stewart; Carlo Ventura; Lewis J Rubin
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

3.  Reversible pulmonary hypertension related to thalidomide treatment for multiple myeloma.

Authors:  Antonio Villa; Anna Alice Mazzola; Stefano Ghio; Elena Martinoli; Pietro Marino
Journal:  Case Rep Oncol       Date:  2011-09-28

4.  Severe Pulmonary Hypertension Caused by Smoldering Plasma Cell Myeloma: An Autopsy Case of POEMS Syndrome.

Authors:  Katsuya Chinen; Yasunori Fujioka
Journal:  Case Rep Med       Date:  2012-11-29

5.  Thalidomide-Related Eosinophilic Pneumonia: A case report and brief literature review.

Authors:  Lisa Tilluckdharry; Robert Dean; Carol Farver; Muzaffar Ahmad
Journal:  Cases J       Date:  2008-09-08

6.  Clinical impact of echocardiography-defined pulmonary hypertension on the clinical outcome in patients with multiple myeloma.

Authors:  SungA Bae; Kye Hun Kim; Hyun Ju Yoon; Hyung Yoon Kim; Hyukjin Park; Jae Yeong Cho; Min Chul Kim; Yongcheol Kim; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.